Table 1 Global Response Assessment Scale Number Response Grading (%) Outcome 1 Significantly worse 0 Failure of the therapy 2 Somewhat worse 1 to 25 Failure of the therapy 3 Unchanged (neither worse nor better) 26 to 50 Failure of the therapy 4 Somewhat improved 51 to 75 Successful therapy 5 Significantly improved 76 to 100 Successful therapy Inclusion criteria This study included patients with moderate to severe interstitial cystitis who had participated in the experimental trial conducted in January 2023 at the UroGyn Specialists of Florida clinic using the nonFDA-approved BPC-157 peptide
It is not a cosmetic serum and is not intended for human or veterinary use
Note, the results were obtained with parenteral and per-oral application (i.e., BPC 157 is stable in gastric juice more than 24 h, unlike standard growth factors) (1-7)
The primary difference is that women may be more sensitive to side effects and should be more cautious when titrating to the advanced range
You've been told it's "just stress," "just aging," or "something you'll have to live with." You've smiled through the pain at your kid's soccer game, pushed through another workday feeling like your body is actively working against you, and wondered if this is just what life looks like now
An FDA advisory committee recommended BPC-157 for the compounding ingredient list, 86